Deleted Tweet from Rep. Kim Schrier, M.D.

As a doctor with Type 1 diabetes, I am thrilled to see the FDA implement my bill, the Protecting Access to Biosimilar Act that will bring biosimilars, more commonly known as generics, to market. This is a new category of generics that will significantly reduce the cost of insulin QT @AP: U.S. regulators are making it easier to get a cheaper and similar version of a brand-name insulin at the drugstore.… https://t.co/RfMpRormab)